| Product name | Recombinant SARS-CoV-2 3C-like Proteinase Protein |
|---|---|
| Catalog No. | RP01270LQ |
| Description | Recombinant SARS-CoV-2(2019-nCoV) 3C-like Proteinase is produced by E. coli expression system. The target protein is expressed with sequence (Ser1-Gln306) of SARS-COV-2(2019-nCoV) 3C-like Proteinase (Accession #YP_009725301.1) fused with an initial Met, a 6×His, Avi tag at the N-terminus. |
| Purity | > 95% by SDS-PAGE. |
| Endotoxin | < 1.0 EU/μg of the protein by LAL method. |
| Formulation | Supplied as a 0.22 μm filtered solution in 20mM HEPES, 120mM NaCl, 10% Glycerol, 2mM TCEP, pH7.4Contact us for customized product form or formulation. |
| Species | SARS-CoV-2 |
| Calculated MW | 36.45 kDa |
| Synonym | 3CLpro; NSP1; NSP10; NSP12; NSP13; NSP14; NSP15; NSP16; NSP2; NSP3; NSP4; NSP6; NSP7; NSP8; NSP9 |
|---|---|
| Expression Host | E. coli |
| Tag | N-His&Avi |
| Gene ID |
| Storage | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |
|---|
* For research use only. Not for therapeutic or diagnostic purposes.
Publishing research using RP01270LQ? Please let us know so that we can cite the reference in this datasheet.
